JP2004529884A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529884A5
JP2004529884A5 JP2002567231A JP2002567231A JP2004529884A5 JP 2004529884 A5 JP2004529884 A5 JP 2004529884A5 JP 2002567231 A JP2002567231 A JP 2002567231A JP 2002567231 A JP2002567231 A JP 2002567231A JP 2004529884 A5 JP2004529884 A5 JP 2004529884A5
Authority
JP
Japan
Prior art keywords
radiopharmaceutical composition
formula
substituted
radiopharmaceutical
biomolecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002567231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529884A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/005155 external-priority patent/WO2002067859A2/en
Publication of JP2004529884A publication Critical patent/JP2004529884A/ja
Publication of JP2004529884A5 publication Critical patent/JP2004529884A5/ja
Pending legal-status Critical Current

Links

JP2002567231A 2001-02-26 2002-02-22 金属放射性医薬のためのアスコルビン酸類似体 Pending JP2004529884A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27138901P 2001-02-26 2001-02-26
PCT/US2002/005155 WO2002067859A2 (en) 2001-02-26 2002-02-22 Ascorbic acid analogs for metalloradiopharmaceuticals

Publications (2)

Publication Number Publication Date
JP2004529884A JP2004529884A (ja) 2004-09-30
JP2004529884A5 true JP2004529884A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=23035343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567231A Pending JP2004529884A (ja) 2001-02-26 2002-02-22 金属放射性医薬のためのアスコルビン酸類似体

Country Status (12)

Country Link
US (1) US6713042B2 (cg-RX-API-DMAC7.html)
EP (1) EP1365813A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004529884A (cg-RX-API-DMAC7.html)
CN (1) CN1503680A (cg-RX-API-DMAC7.html)
AU (1) AU2002253999A1 (cg-RX-API-DMAC7.html)
BR (1) BR0207315A (cg-RX-API-DMAC7.html)
CA (1) CA2438204A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20032597A3 (cg-RX-API-DMAC7.html)
HU (1) HUP0304083A2 (cg-RX-API-DMAC7.html)
IL (1) IL157359A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007595A (cg-RX-API-DMAC7.html)
WO (1) WO2002067859A2 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305463A1 (de) * 2003-02-04 2004-08-12 Schering Ag Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel
US20050089470A1 (en) * 2003-10-24 2005-04-28 Johnson Bruce F. Labeled peptides for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
US20050089471A1 (en) * 2003-10-24 2005-04-28 Johnson Bruce F. Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
US20060210479A1 (en) * 2004-08-10 2006-09-21 Dow Global Technologies Inc. Targeting chelants and chelates
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
JP5238496B2 (ja) * 2006-05-19 2013-07-17 日本メジフィジックス株式会社 新規アミロイド親和性化合物
WO2007148088A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare Limited Radiopharmaceutical products
CN101501033B (zh) * 2006-06-21 2012-08-01 通用电气医疗有限公司 对淀粉状蛋白具有亲和性的化合物
US20100056826A1 (en) * 2006-11-09 2010-03-04 Nihon Medi-Physicis Co., Ltd. Radioactive diagnostic imaging agent
WO2008059714A1 (en) * 2006-11-17 2008-05-22 Nihon Medi-Physics Co., Ltd. Novel compounds with affinity for amyloid
CN101595108A (zh) * 2006-11-30 2009-12-02 日本医事物理股份有限公司 对淀粉状蛋白具有亲和性的新化合物
US8790620B2 (en) * 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
EP2119458B9 (en) 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
TW200918102A (en) * 2007-10-24 2009-05-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
KR20100089858A (ko) * 2007-10-30 2010-08-12 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법
JPWO2009057577A1 (ja) * 2007-10-30 2011-03-10 日本メジフィジックス株式会社 新規アミロイド親和性化合物の使用及び製造方法
US20100284912A1 (en) * 2007-12-04 2010-11-11 Bracco Diagnostics Inc. Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients
CA2736237A1 (en) * 2008-09-05 2010-03-11 Molecular Insight Pharmaceuticals, Inc. Pharmaceutical composition of a radioiodinated benzamide derivative and methods of making the same
FR2942227B1 (fr) * 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
CN102458396B (zh) 2009-04-15 2017-05-10 兰休斯医疗成像公司 使用抗坏血酸稳定化放射性药物组合物
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates
WO2013093099A1 (en) * 2011-12-22 2013-06-27 Piramal Imaging Sa Stabilization of peptidic radiopharmaceuticals using uric acid or derivatives thereof
US9550704B2 (en) 2012-05-24 2017-01-24 Futurechem Co., Ltd. Method for synthesizing radiopharmaceuticals using a cartridge
US20140147381A1 (en) * 2012-11-29 2014-05-29 Gregory David Espenan 89zr compounds, to include somatostatin, apparatus and products comprising such compounds, methods of making same, and methods of using same for radio imaging and/or treatment
CA2901231C (en) * 2013-02-15 2020-06-23 Thomas Jefferson University Kit comprising lyophilized compositions for tumor imaging
CN107207566B (zh) * 2014-11-27 2021-01-22 赛特瑞恩股份有限公司 稳定的肽缀合抗坏血酸衍生物、用于制备其的方法和包含其的化妆品组合物
TWI604853B (zh) * 2016-05-03 2017-11-11 行政院原子能委員會核能研究所 放射免疫複合體、診療劑及套組
CN107167540B (zh) * 2017-07-08 2019-07-30 万舒(北京)医药科技有限公司 测定人尿液生物样品中的DTPA-Zn的方法
KR102207372B1 (ko) * 2020-03-31 2021-01-27 재단법인 아산사회복지재단 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU167378B (cg-RX-API-DMAC7.html) * 1972-05-08 1975-09-27
US4504462A (en) * 1982-06-10 1985-03-12 Mallinckrodt, Inc. Process for making a lyophilized product for use in skeletal imaging
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
ATE102442T1 (de) * 1989-10-09 1994-03-15 Unilever Nv Verfahren zur herstellung von essbaren aufstrichen und anlage dafuer.
DE69231469T2 (de) * 1991-08-29 2001-01-25 Mallinckrodt Medical, Inc. Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
WO1997028181A2 (en) * 1996-02-02 1997-08-07 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
US6066309A (en) * 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
WO2002004030A2 (en) * 2000-07-06 2002-01-17 Bristol-Myers Squibb Pharma Company Stable radiopharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP7650938B2 (ja) 鉛またはトリウム放射性核種に連結されたpsma標的化化合物を含む錯体
JP3054346B2 (ja) ペプチド類
JP2007297404A (ja) 腫瘍造影剤としてのヌクレオチドポリリン酸に結合された放射性核種
CA2479109A1 (en) Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
EP0600992A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
DE69837038T2 (de) Tetraaza- oder n2s2-komplexanten, und deren verwendung in der radiodiagnostik oder radiotherapie
AU691806B2 (en) Chelating agents of the type XN1S1O1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
US20080260636A1 (en) Stabilization of radionuclide-containing compositions
KR100845449B1 (ko) 테크네튬-99m 니트리드 이종복합체를 함유하는영상진단용 방사선 의약품
DE19860289C2 (de) Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
EP0630264A1 (en) Ligands for improving metal chelate formation kinetics
US5961954A (en) Chealators of type XN1 S1 X1 for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
KR102548998B1 (ko) 혈전영상을 위한 방사성의약품 및 조성물
HU221882B1 (hu) Komplexvegyületek véredénybetegségek diagnózisához
NZ263793A (en) Compounds suitable for forming tc and re chelates, radiopharmaceutical compositions thereof
WO2026037958A1 (en) Fapi theranostic compounds assembled with tetrazine ligation
JPH11509224A (ja) 遷移金属窒化物錯体を含有し迅速な心筋クリアランスを有する心臓向性放射性製剤
JPS6087228A (ja) 心臓像形成用組成物
JPH11505852A (ja) 隔離された画像診断剤
PL147612B1 (en) Method of obtaining a pharmaceutic with affinity to neoplastic tissues
JPH08507787A (ja) 放射線撮影イメージング剤に有用なヘテロ環基部を有する窒素−硫黄配位子類